Apple Watch’s restored blood oxygen tracking attracts another lawsuit
1 min read
Summary
Medical tech company Masimo has filed a lawsuit against the US Customs and Border Protection (CBP) authority, claiming the agency failed to notify the company before allowing Apple to restore the blood oxygen tracking feature on its Apple Watches.
Masimo claims it only found out about the CBP’s decision to reverse an existing ban on the feature at the same time as the general public, and was not given an opportunity to review or challenge the ruling prior to Apple announcing the feature’s return.
Masimo is also critical of the CBP for allegedly not upholding its usual processes, pointing out that Apple has continued to infringe upon Masimo’s patents.
Furthermore, the complaint alleges that Apple has made “a series of substantial investments in the US” following the initial denial of its appeal to overturn the ITC ban.